Literature DB >> 28956166

Acute and chronic changes in baroreflex sensitivity in hypobaric vs. normobaric hypoxia.

Nicolas Bourdillon1, Jonas Saugy2, Laurent Schmitt2,3, Thomas Rupp4, Sasan Yazdani5, Jean-Marc Vesin5, Grégoire P Millet2.   

Abstract

Normobaric hypoxia (NH) is used as a surrogate for hypobaric hypoxia (HH). Recent studies reported physiological differences between NH and HH. Baroreflex sensitivity (BRS) decreases at altitude or following intense training. However, until now no study compared the acute and chronic changes of BRS in NH vs. HH. First, BRS was assessed in 13 healthy male subjects prior and after 20 h of exposure at 3450 m (study 1), and second in 15 well-trained athletes prior and after 18 days of "live-high train-low" (LHTL) at 2250 m (study 2) in NH vs. HH. BRS decreased (p < 0.05) to the same extent in NH and HH after 20 h of hypoxia and after LHTL. These results confirm that altitude decreases BRS but the decrease is similar between HH and NH. The persistence of this decrease after the cessation of a chronic exposure is new and does not differ between HH and NH. The previously reported physiological differences between NH and HH do not appear strong enough to induce different BRS responses.

Entities:  

Keywords:  Altitude; Baroreflex; Hypobaric hypoxia; LHTL; Normobaric hypoxia

Mesh:

Substances:

Year:  2017        PMID: 28956166     DOI: 10.1007/s00421-017-3726-6

Source DB:  PubMed          Journal:  Eur J Appl Physiol        ISSN: 1439-6319            Impact factor:   3.078


  36 in total

1.  Cardiac baroreflex control in humans during and immediately after brief exposure to simulated high altitude.

Authors:  Frédéric Roche; Claire Reynaud; Martin Garet; Vincent Pichot; Frédéric Costes; Jean-Claude Barthélémy
Journal:  Clin Physiol Funct Imaging       Date:  2002-09       Impact factor: 2.273

Review 2.  Determinants of baroreflex sensitivity in health and disease: from correlates to causality.

Authors:  Mark W Chapleau
Journal:  Clin Auton Res       Date:  2003-10       Impact factor: 4.435

3.  Increased sympathetic and decreased parasympathetic cardiovascular modulation in normal humans with acute sleep deprivation.

Authors:  Xu Zhong; H John Hilton; Gregory J Gates; Sanja Jelic; Yaakov Stern; Matthew N Bartels; Ronald E Demeersman; Robert C Basner
Journal:  J Appl Physiol (1985)       Date:  2005-02-17

4.  Comparison of Sleep Disorders between Real and Simulated 3,450-m Altitude.

Authors:  Raphaël Heinzer; Jonas J Saugy; Thomas Rupp; Nadia Tobback; Raphael Faiss; Nicolas Bourdillon; José Haba Rubio; Grégoire P Millet
Journal:  Sleep       Date:  2016-08-01       Impact factor: 5.849

Review 5.  Neural reflex regulation of arterial pressure in pathophysiological conditions: interplay among the baroreflex, the cardiopulmonary reflexes and the chemoreflex.

Authors:  E C Vasquez; S S Meyrelles; H Mauad; A M Cabral
Journal:  Braz J Med Biol Res       Date:  1997-04       Impact factor: 2.590

6.  Baroreflex sensitivity and heart-rate variability in prediction of total cardiac mortality after myocardial infarction. ATRAMI (Autonomic Tone and Reflexes After Myocardial Infarction) Investigators.

Authors:  M T La Rovere; J T Bigger; F I Marcus; A Mortara; P J Schwartz
Journal:  Lancet       Date:  1998-02-14       Impact factor: 79.321

7.  Cardiovascular neural regulation during and after prolonged high altitude exposure.

Authors:  A Ponchia; D Noventa; M Bertaglia; R Carretta; M Zaccaria; G Miraglia; P Pascotto; G Buja
Journal:  Eur Heart J       Date:  1994-11       Impact factor: 29.983

8.  Cardiac Baroreflex Variability and Resetting during Sustained Mild Effort.

Authors:  Mair Zamir; Mark B Badrov; T Dylan Olver; J Kevin Shoemaker
Journal:  Front Physiol       Date:  2017-05-05       Impact factor: 4.566

9.  Same Performance Changes after Live High-Train Low in Normobaric vs. Hypobaric Hypoxia.

Authors:  Jonas J Saugy; Laurent Schmitt; Anna Hauser; Guillaume Constantin; Roberto Cejuela; Raphael Faiss; Jon P Wehrlin; Jérémie Rosset; Neil Robinson; Grégoire P Millet
Journal:  Front Physiol       Date:  2016-04-19       Impact factor: 4.566

10.  Therapeutic Use of Exercising in Hypoxia: Promises and Limitations.

Authors:  Gregoire P Millet; Tadej Debevec; Franck Brocherie; Davide Malatesta; Olivier Girard
Journal:  Front Physiol       Date:  2016-06-10       Impact factor: 4.566

View more
  6 in total

1.  Delayed parasympathetic reactivation and sympathetic withdrawal following maximal cardiopulmonary exercise testing (CPET) in hypoxia.

Authors:  Alessandro Fornasiero; Aldo Savoldelli; Spyros Skafidas; Federico Stella; Lorenzo Bortolan; Gennaro Boccia; Andrea Zignoli; Federico Schena; Laurent Mourot; Barbara Pellegrini
Journal:  Eur J Appl Physiol       Date:  2018-07-26       Impact factor: 3.078

Review 2.  Therapeutic approach for digestive system cancers and potential implications of exercise under hypoxia condition: what little is known? a narrative review.

Authors:  Sergio Pérez Regalado; Josefa León; Belén Feriche
Journal:  J Cancer Res Clin Oncol       Date:  2022-02-14       Impact factor: 4.322

3.  Post-exercise cardiac autonomic and cardiovascular responses to heart rate-matched and work rate-matched hypoxic exercise.

Authors:  Alessandro Fornasiero; Andrea Zignoli; Mark Rakobowchuk; Federico Stella; Aldo Savoldelli; Spyros Skafidas; Federico Schena; Barbara Pellegrini; Laurent Mourot
Journal:  Eur J Appl Physiol       Date:  2021-04-03       Impact factor: 3.078

4.  Sex differences during a cold-stress test in normobaric and hypobaric hypoxia: A randomized controlled crossover study.

Authors:  Erich Hohenauer; Wolfgang Taube; Livia Freitag; Ron Clijsen
Journal:  Front Physiol       Date:  2022-09-23       Impact factor: 4.755

Review 5.  Limitation of Maximal Heart Rate in Hypoxia: Mechanisms and Clinical Importance.

Authors:  Laurent Mourot
Journal:  Front Physiol       Date:  2018-07-23       Impact factor: 4.566

Review 6.  Technical Feasibility and Physiological Relevance of Hypoxic Cell Culture Models.

Authors:  Jiri Pavlacky; Jan Polak
Journal:  Front Endocrinol (Lausanne)       Date:  2020-02-21       Impact factor: 5.555

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.